Seoul Pharma Co. Ltd Net Asset Momentum
Seoul Pharma Co. Ltd net asset momentum. Seoul Pharma Co. Ltd (018680) recorded a net asset momentum of 4.2% as of December 2024, with net assets of ₩40.17 Billion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Seoul Pharma Co. Ltd (018680) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Seoul Pharma Co. Ltd (2012–2024)
Net asset momentum of Seoul Pharma Co. Ltd from 2012 to 2024. This chart tracks Seoul Pharma Co. Ltd's year-over-year net asset growth across 13 annual reporting periods from 2012 to 2024. The most recent momentum reading is +4.2%, with net assets of ₩40.17 Billion KRW as of December 2024. See 018680 net assets for net asset value and shareholders' equity analysis.
Seoul Pharma Co. Ltd Net Asset Momentum by Year (2012–2024)
Seoul Pharma Co. Ltd net asset momentum by year from 2012 to 2024. The table below shows the complete annual net asset history for Seoul Pharma Co. Ltd from 2012 to 2024, covering 13 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Seoul Pharma Co. Ltd stock valuation.
| Year | Net Assets (KRW) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | ₩40.17 Billion | ₩71.62 Billion | ₩31.45 Billion | ▲ +4.2% |
| 2023 | ₩38.56 Billion | ₩63.31 Billion | ₩24.74 Billion | ▲ +8.9% |
| 2022 | ₩35.42 Billion | ₩62.43 Billion | ₩27.01 Billion | ▲ +86.8% |
| 2021 | ₩18.96 Billion | ₩62.25 Billion | ₩43.29 Billion | ▼ -34.3% |
| 2020 | ₩28.85 Billion | ₩65.09 Billion | ₩36.23 Billion | ▲ +1.4% |
| 2019 | ₩28.45 Billion | ₩70.89 Billion | ₩42.44 Billion | ▼ -43.5% |
| 2018 | ₩50.31 Billion | ₩90.57 Billion | ₩40.25 Billion | ▼ -6.6% |
| 2017 | ₩53.86 Billion | ₩86.93 Billion | ₩33.08 Billion | ▲ +28.0% |
| 2016 | ₩42.07 Billion | ₩92.54 Billion | ₩50.47 Billion | ▲ +25.5% |
| 2015 | ₩33.53 Billion | ₩82.68 Billion | ₩49.15 Billion | ▲ +7.8% |
| 2014 | ₩31.10 Billion | ₩78.98 Billion | ₩47.88 Billion | ▼ -3.6% |
| 2013 | ₩32.25 Billion | ₩71.42 Billion | ₩39.17 Billion | ▲ +27.1% |
| 2012 | ₩25.38 Billion | ₩60.68 Billion | ₩35.29 Billion | — |